Luxpharma SA
1.5 FTELuxpharma reported total assets of 602,345 € at the end of the 2025 financial year (annual accounts filed with the NBB on 27 Aug 2026), with 1.5 full-time equivalent.
The score of Luxpharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +16 % Total assets +13 % Headcount (avg FTE) -32 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Luxpharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 56,880 € | ||||
| Equity | 409,055 € | ||||
| Cash | 198,970 € | ||||
| EBITDA | 94,405 € | ||||
| Total assets | 602,345 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 27 Aug 2026
- Year ended 31 Dec 2024filed on 26 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 27 Aug 2022
Luxpharma's financial analysis
- Solvency67.9%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Luxpharma
Luxpharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0466.659.179
- VAT number
- BE0466659179
- Peppol
- Registered · 0208:0466659179 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 09 Aug 1999
- Registered office
- 6831 Bouillon
- Size
- Micro · 1.5 FTE
- Latest accounts
- 2025 · filed on 27 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Luxpharma (SA) has been based in Bouillon since 1999, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 56,880 € and equity of 409,055 €; its revenue is not published. With 1.5 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 67.9%, above the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Luxpharma
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Herzet - Pratte Retail sale of pharmaceutical products Beloeil · balance sheet 602,824 €
- Apotheek Dolhain Retail sale of pharmaceutical products Brasschaat · balance sheet 601,652 €
- Diapharma Retail sale of pharmaceutical products Leuven · balance sheet 600,343 €
- Pharmaco Retail sale of pharmaceutical products Sint-Niklaas · balance sheet 604,705 €
- De Bosmolens Retail sale of pharmaceutical products Izegem · balance sheet 599,551 €
- Etis Pharma Retail sale of pharmaceutical products Pont-à-Celles · balance sheet 599,365 €
- Dubart - Lamalle Retail sale of pharmaceutical products Chaudfontaine · balance sheet 599,335 €
- Dorpsapotheek Waarschoot Retail sale of pharmaceutical products Lievegem · balance sheet 606,408 €
Frequently asked questions about Luxpharma
What is the revenue of Luxpharma?
Luxpharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Luxpharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0466659179 for Luxpharma, if the company is VAT-registered. Its company number (CBE) is 0466.659.179.
Where is the registered office of Luxpharma?
According to the CBE register, the registered office of Luxpharma is in 6831 Bouillon.
What is the equity of Luxpharma?
At the close of the 2025 financial year, the equity of Luxpharma amounts to 409,055 €, a solvency of 67.9% of total assets.
How many people work at Luxpharma?
1.5 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Luxpharma?
The register lists 4 active mandates at Luxpharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Luxpharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →